- Report
- October 2024
- 180 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 191 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- December 2024
- 16 Pages
Global
From €13662EUR$14,995USD£11,864GBP
- Report
- November 2024
- 361 Pages
Global
From €3827EUR$4,200USD£3,323GBP
- Report
- October 2024
- 156 Pages
Global
From €2724EUR$2,990USD£2,366GBP
- Report
- October 2024
- 139 Pages
Global
From €2724EUR$2,990USD£2,366GBP
- Report
- September 2024
- 253 Pages
Global
From €2232EUR$2,450USD£1,938GBP
- Report
- August 2024
- 322 Pages
Global
From €2232EUR$2,450USD£1,938GBP
- Report
- May 2024
- 139 Pages
Global
From €5921EUR$6,499USD£5,142GBP
- Report
- October 2024
- 187 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 184 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 185 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- August 2024
- 120 Pages
Global
From €5421EUR$5,950USD£4,707GBP
- Report
- July 2024
- 120 Pages
Global
From €5421EUR$5,950USD£4,707GBP
- Report
- August 2024
- 322 Pages
Global
From €3827EUR$4,200USD£3,323GBP
- Report
- March 2025
- 193 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- March 2025
- 193 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 193 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 182 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 192 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more